Concepts (248)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lenses, Intraocular | 34 | 2026 | 215 | 6.550 |
Why?
|
| Lens Implantation, Intraocular | 32 | 2026 | 186 | 5.250 |
Why?
|
| Phacoemulsification | 25 | 2026 | 132 | 4.620 |
Why?
|
| Astigmatism | 14 | 2025 | 113 | 3.980 |
Why?
|
| Cornea | 22 | 2024 | 566 | 3.490 |
Why?
|
| Refraction, Ocular | 28 | 2026 | 184 | 3.350 |
Why?
|
| Corneal Topography | 17 | 2024 | 140 | 2.740 |
Why?
|
| Biometry | 17 | 2026 | 102 | 2.180 |
Why?
|
| Myopia | 11 | 2024 | 120 | 2.050 |
Why?
|
| Visual Acuity | 30 | 2026 | 537 | 2.000 |
Why?
|
| Optics and Photonics | 12 | 2026 | 106 | 1.930 |
Why?
|
| Cataract Extraction | 7 | 2024 | 129 | 1.800 |
Why?
|
| Diagnostic Techniques, Ophthalmological | 10 | 2018 | 84 | 1.690 |
Why?
|
| Axial Length, Eye | 9 | 2024 | 37 | 1.360 |
Why?
|
| Cataract | 7 | 2024 | 152 | 1.090 |
Why?
|
| Ophthalmology | 5 | 2024 | 178 | 1.040 |
Why?
|
| Cytomegalovirus Retinitis | 5 | 2013 | 15 | 0.900 |
Why?
|
| AIDS-Related Opportunistic Infections | 5 | 2013 | 132 | 0.840 |
Why?
|
| Antiretroviral Therapy, Highly Active | 6 | 2013 | 260 | 0.830 |
Why?
|
| Corneal Diseases | 3 | 2019 | 94 | 0.820 |
Why?
|
| Academies and Institutes | 4 | 2024 | 81 | 0.810 |
Why?
|
| Keratoconus | 3 | 2023 | 47 | 0.780 |
Why?
|
| Technology Assessment, Biomedical | 2 | 2020 | 31 | 0.770 |
Why?
|
| Corneal Injuries | 2 | 2024 | 35 | 0.760 |
Why?
|
| Refractive Surgical Procedures | 4 | 2024 | 40 | 0.730 |
Why?
|
| Keratoplasty, Penetrating | 1 | 2021 | 48 | 0.720 |
Why?
|
| Refractive Errors | 4 | 2018 | 59 | 0.720 |
Why?
|
| Photorefractive Keratectomy | 6 | 2021 | 65 | 0.710 |
Why?
|
| Corneal Wavefront Aberration | 3 | 2024 | 13 | 0.700 |
Why?
|
| Iris Diseases | 2 | 2024 | 11 | 0.690 |
Why?
|
| Corneal Pachymetry | 4 | 2018 | 17 | 0.690 |
Why?
|
| Pseudophakia | 5 | 2026 | 37 | 0.640 |
Why?
|
| Eye Diseases | 2 | 2024 | 108 | 0.640 |
Why?
|
| Ophthalmic Solutions | 2 | 2019 | 88 | 0.630 |
Why?
|
| Multifocal Intraocular Lenses | 2 | 2017 | 4 | 0.620 |
Why?
|
| Anterior Eye Segment | 2 | 2017 | 24 | 0.610 |
Why?
|
| Serum | 1 | 2019 | 45 | 0.610 |
Why?
|
| Microsurgery | 2 | 2012 | 64 | 0.590 |
Why?
|
| Keratomileusis, Laser In Situ | 5 | 2024 | 84 | 0.560 |
Why?
|
| Eye Foreign Bodies | 1 | 2018 | 9 | 0.560 |
Why?
|
| Interferometry | 2 | 2017 | 21 | 0.550 |
Why?
|
| Corneal Ulcer | 1 | 2018 | 53 | 0.540 |
Why?
|
| Tomography, Optical Coherence | 10 | 2026 | 463 | 0.540 |
Why?
|
| Surgical Wound Dehiscence | 2 | 2015 | 50 | 0.540 |
Why?
|
| Humans | 79 | 2026 | 131504 | 0.540 |
Why?
|
| Eye Infections, Bacterial | 1 | 2018 | 79 | 0.530 |
Why?
|
| Models, Anatomic | 1 | 2018 | 107 | 0.520 |
Why?
|
| Prospective Studies | 20 | 2026 | 6485 | 0.480 |
Why?
|
| Dry Eye Syndromes | 1 | 2019 | 293 | 0.460 |
Why?
|
| Prosthesis Design | 7 | 2025 | 610 | 0.460 |
Why?
|
| Middle Aged | 34 | 2026 | 28839 | 0.450 |
Why?
|
| Acanthamoeba Keratitis | 2 | 2021 | 16 | 0.450 |
Why?
|
| Retrospective Studies | 29 | 2026 | 17648 | 0.450 |
Why?
|
| Keratotomy, Radial | 2 | 2016 | 22 | 0.450 |
Why?
|
| Reproducibility of Results | 12 | 2024 | 2985 | 0.440 |
Why?
|
| Sclera | 3 | 2026 | 45 | 0.440 |
Why?
|
| Artificial Lens Implant Migration | 3 | 2026 | 8 | 0.420 |
Why?
|
| Descemet Membrane | 2 | 2012 | 10 | 0.400 |
Why?
|
| Epithelium, Corneal | 4 | 2024 | 174 | 0.400 |
Why?
|
| Aged, 80 and over | 13 | 2026 | 6916 | 0.400 |
Why?
|
| Iris | 5 | 2024 | 36 | 0.390 |
Why?
|
| Corneal Endothelial Cell Loss | 1 | 2012 | 3 | 0.380 |
Why?
|
| Lasers, Excimer | 4 | 2021 | 63 | 0.370 |
Why?
|
| Aged | 23 | 2026 | 21238 | 0.360 |
Why?
|
| Hyperopia | 3 | 2021 | 59 | 0.350 |
Why?
|
| Corneal Stroma | 3 | 2021 | 75 | 0.310 |
Why?
|
| Male | 39 | 2026 | 65158 | 0.310 |
Why?
|
| Suture Techniques | 6 | 2017 | 177 | 0.310 |
Why?
|
| Female | 39 | 2026 | 71087 | 0.300 |
Why?
|
| Adult | 23 | 2026 | 31666 | 0.270 |
Why?
|
| Functional Laterality | 1 | 2008 | 183 | 0.260 |
Why?
|
| Aberrometry | 2 | 2024 | 5 | 0.250 |
Why?
|
| Antiprotozoal Agents | 2 | 2021 | 42 | 0.240 |
Why?
|
| Eye | 2 | 2024 | 228 | 0.230 |
Why?
|
| Artificial Intelligence | 3 | 2024 | 329 | 0.220 |
Why?
|
| Organ Size | 2 | 2018 | 434 | 0.220 |
Why?
|
| Eye Burns | 1 | 2024 | 16 | 0.220 |
Why?
|
| Amnion | 1 | 2024 | 41 | 0.220 |
Why?
|
| Burns, Chemical | 1 | 2024 | 30 | 0.210 |
Why?
|
| CD4 Lymphocyte Count | 5 | 2013 | 228 | 0.210 |
Why?
|
| Uveitis | 2 | 2011 | 33 | 0.210 |
Why?
|
| Ectopia Lentis | 3 | 2015 | 11 | 0.210 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2012 | 496 | 0.210 |
Why?
|
| Ganciclovir | 1 | 2013 | 102 | 0.190 |
Why?
|
| Retinopathy of Prematurity | 2 | 2016 | 64 | 0.190 |
Why?
|
| Wound Healing | 3 | 2012 | 476 | 0.180 |
Why?
|
| Keratitis | 2 | 2021 | 105 | 0.180 |
Why?
|
| Phosphorylcholine | 1 | 2021 | 31 | 0.180 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2024 | 152 | 0.170 |
Why?
|
| Interleukin-10 Receptor alpha Subunit | 1 | 2011 | 4 | 0.170 |
Why?
|
| Postoperative Complications | 6 | 2019 | 3113 | 0.170 |
Why?
|
| Receptors, CCR5 | 1 | 2011 | 30 | 0.170 |
Why?
|
| Receptors, CCR2 | 1 | 2011 | 24 | 0.170 |
Why?
|
| Chemokine CXCL12 | 1 | 2011 | 36 | 0.170 |
Why?
|
| Treatment Outcome | 12 | 2024 | 12936 | 0.170 |
Why?
|
| Fourier Analysis | 2 | 2018 | 55 | 0.170 |
Why?
|
| Ligaments | 1 | 2020 | 20 | 0.160 |
Why?
|
| Lens, Crystalline | 2 | 2018 | 101 | 0.150 |
Why?
|
| United States | 8 | 2024 | 11794 | 0.150 |
Why?
|
| Amblyopia | 1 | 2019 | 34 | 0.150 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2010 | 222 | 0.150 |
Why?
|
| Preservation, Biological | 1 | 2018 | 10 | 0.140 |
Why?
|
| Intraoperative Complications | 2 | 2017 | 155 | 0.140 |
Why?
|
| China | 1 | 2019 | 287 | 0.140 |
Why?
|
| Follow-Up Studies | 8 | 2019 | 5277 | 0.140 |
Why?
|
| Light | 2 | 2017 | 174 | 0.140 |
Why?
|
| Photography | 2 | 2015 | 80 | 0.140 |
Why?
|
| Tissue Adhesives | 1 | 2018 | 38 | 0.140 |
Why?
|
| Fuchs' Endothelial Dystrophy | 1 | 2017 | 6 | 0.140 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2016 | 3411 | 0.140 |
Why?
|
| Descemet Stripping Endothelial Keratoplasty | 1 | 2017 | 10 | 0.130 |
Why?
|
| Eyelids | 1 | 2018 | 108 | 0.130 |
Why?
|
| Antiviral Agents | 1 | 2013 | 812 | 0.130 |
Why?
|
| Anti-HIV Agents | 1 | 2010 | 359 | 0.130 |
Why?
|
| Anterior Chamber | 1 | 2017 | 27 | 0.130 |
Why?
|
| Dilatation, Pathologic | 1 | 2017 | 80 | 0.130 |
Why?
|
| Collagen | 1 | 2018 | 289 | 0.120 |
Why?
|
| Models, Theoretical | 1 | 2018 | 365 | 0.120 |
Why?
|
| Term Birth | 1 | 2016 | 35 | 0.120 |
Why?
|
| Reference Standards | 1 | 2017 | 231 | 0.120 |
Why?
|
| Retinal Detachment | 2 | 2010 | 42 | 0.120 |
Why?
|
| Cyclophosphamide | 1 | 2018 | 441 | 0.120 |
Why?
|
| Healthy Volunteers | 1 | 2015 | 157 | 0.110 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2016 | 155 | 0.110 |
Why?
|
| Patient Care Planning | 1 | 2016 | 123 | 0.110 |
Why?
|
| Tissue Donors | 1 | 2018 | 502 | 0.110 |
Why?
|
| Lens Capsule, Crystalline | 1 | 2014 | 24 | 0.110 |
Why?
|
| Diagnostic Imaging | 1 | 2017 | 300 | 0.110 |
Why?
|
| Practice Guidelines as Topic | 1 | 2011 | 1305 | 0.110 |
Why?
|
| Referral and Consultation | 1 | 2018 | 566 | 0.110 |
Why?
|
| Intellectual Disability | 1 | 2021 | 1072 | 0.110 |
Why?
|
| gamma-Linolenic Acid | 1 | 2013 | 3 | 0.100 |
Why?
|
| Immunosuppressive Agents | 1 | 2018 | 667 | 0.100 |
Why?
|
| Corneal Surgery, Laser | 1 | 2013 | 11 | 0.100 |
Why?
|
| Vitrectomy | 2 | 2010 | 41 | 0.100 |
Why?
|
| Tears | 2 | 2013 | 185 | 0.100 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2016 | 613 | 0.100 |
Why?
|
| Postoperative Period | 3 | 2018 | 330 | 0.100 |
Why?
|
| Keratoconjunctivitis Sicca | 1 | 2013 | 50 | 0.100 |
Why?
|
| Young Adult | 7 | 2019 | 10092 | 0.100 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2013 | 81 | 0.100 |
Why?
|
| Endothelium, Corneal | 1 | 2012 | 27 | 0.100 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2016 | 634 | 0.090 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2012 | 124 | 0.090 |
Why?
|
| Intraocular Pressure | 1 | 2013 | 133 | 0.090 |
Why?
|
| Cell Count | 1 | 2012 | 217 | 0.090 |
Why?
|
| Disease Management | 1 | 2016 | 563 | 0.090 |
Why?
|
| Microscopy, Acoustic | 2 | 2024 | 16 | 0.090 |
Why?
|
| Premature Birth | 1 | 2016 | 415 | 0.090 |
Why?
|
| Reflex, Pupillary | 1 | 2010 | 17 | 0.080 |
Why?
|
| Risk Factors | 5 | 2017 | 10952 | 0.080 |
Why?
|
| Meibomian Glands | 1 | 2011 | 43 | 0.080 |
Why?
|
| Pupil Disorders | 1 | 2010 | 18 | 0.080 |
Why?
|
| Clinical Competence | 1 | 2017 | 1050 | 0.080 |
Why?
|
| Eyelid Diseases | 1 | 2011 | 58 | 0.080 |
Why?
|
| Aphakia, Postcataract | 3 | 2017 | 17 | 0.080 |
Why?
|
| Photic Stimulation | 1 | 2010 | 223 | 0.080 |
Why?
|
| Physical Examination | 1 | 2010 | 169 | 0.080 |
Why?
|
| Laser Coagulation | 1 | 2010 | 109 | 0.080 |
Why?
|
| Viral Load | 2 | 2011 | 406 | 0.080 |
Why?
|
| Sjogren's Syndrome | 1 | 2011 | 108 | 0.080 |
Why?
|
| Child, Preschool | 8 | 2021 | 15047 | 0.070 |
Why?
|
| Child | 9 | 2021 | 26239 | 0.070 |
Why?
|
| Benzamidines | 1 | 2008 | 10 | 0.070 |
Why?
|
| Ultrasonography | 1 | 2013 | 972 | 0.070 |
Why?
|
| Vision, Binocular | 1 | 2008 | 31 | 0.070 |
Why?
|
| Contact Lenses | 1 | 2008 | 40 | 0.070 |
Why?
|
| Models, Statistical | 1 | 2010 | 492 | 0.070 |
Why?
|
| Time Factors | 4 | 2019 | 6273 | 0.070 |
Why?
|
| Adolescent | 7 | 2016 | 20917 | 0.070 |
Why?
|
| Internship and Residency | 1 | 2017 | 1213 | 0.070 |
Why?
|
| Neurons | 1 | 2016 | 1990 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 1 | 2018 | 2566 | 0.060 |
Why?
|
| Re-Epithelialization | 1 | 2024 | 12 | 0.060 |
Why?
|
| Disease Progression | 2 | 2011 | 2205 | 0.050 |
Why?
|
| Tonometry, Ocular | 1 | 2024 | 29 | 0.050 |
Why?
|
| Corneal Neovascularization | 1 | 2003 | 13 | 0.050 |
Why?
|
| Prednisolone | 1 | 2003 | 69 | 0.050 |
Why?
|
| Lasers | 1 | 2024 | 114 | 0.050 |
Why?
|
| Drug Implants | 1 | 2013 | 41 | 0.050 |
Why?
|
| Intravitreal Injections | 1 | 2013 | 40 | 0.050 |
Why?
|
| Biomechanical Phenomena | 1 | 2024 | 265 | 0.050 |
Why?
|
| Lissamine Green Dyes | 2 | 2013 | 8 | 0.050 |
Why?
|
| Reoperation | 1 | 2026 | 835 | 0.050 |
Why?
|
| False Positive Reactions | 2 | 2013 | 142 | 0.050 |
Why?
|
| Loteprednol Etabonate | 1 | 2021 | 5 | 0.040 |
Why?
|
| Surgical Flaps | 1 | 2003 | 187 | 0.040 |
Why?
|
| Visual Fields | 1 | 2013 | 141 | 0.040 |
Why?
|
| United States Public Health Service | 1 | 2011 | 5 | 0.040 |
Why?
|
| Drug Substitution | 1 | 2021 | 24 | 0.040 |
Why?
|
| Anti-Allergic Agents | 1 | 2021 | 29 | 0.040 |
Why?
|
| Prevalence | 1 | 2008 | 2692 | 0.040 |
Why?
|
| Swine | 1 | 2024 | 1187 | 0.040 |
Why?
|
| Case-Control Studies | 3 | 2013 | 3452 | 0.040 |
Why?
|
| Microscopy, Confocal | 1 | 2021 | 363 | 0.040 |
Why?
|
| Guideline Adherence | 1 | 2011 | 392 | 0.040 |
Why?
|
| Preoperative Period | 1 | 2018 | 90 | 0.040 |
Why?
|
| Hospitals, County | 1 | 2017 | 22 | 0.030 |
Why?
|
| Vision Tests | 1 | 2017 | 27 | 0.030 |
Why?
|
| Contrast Sensitivity | 1 | 2017 | 33 | 0.030 |
Why?
|
| HIV-1 | 1 | 2011 | 477 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2011 | 1405 | 0.030 |
Why?
|
| Spiral Ganglion | 1 | 2016 | 10 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2013 | 2143 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2010 | 1522 | 0.030 |
Why?
|
| ROC Curve | 1 | 2019 | 615 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 2013 | 2297 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2010 | 1516 | 0.030 |
Why?
|
| Tomography | 1 | 2015 | 34 | 0.030 |
Why?
|
| Genotype | 1 | 2011 | 2655 | 0.030 |
Why?
|
| Central Nervous System | 1 | 2016 | 286 | 0.030 |
Why?
|
| Neuroglia | 1 | 2016 | 223 | 0.030 |
Why?
|
| Incidence | 1 | 2012 | 3344 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2013 | 1788 | 0.030 |
Why?
|
| Fluorescein | 1 | 2013 | 39 | 0.030 |
Why?
|
| HLA-DR Antigens | 1 | 2013 | 70 | 0.030 |
Why?
|
| CD11c Antigen | 1 | 2013 | 40 | 0.030 |
Why?
|
| Pedigree | 1 | 2016 | 1710 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 2013 | 171 | 0.020 |
Why?
|
| Retinoscopy | 1 | 2012 | 8 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2012 | 5120 | 0.020 |
Why?
|
| Rupture | 1 | 2012 | 36 | 0.020 |
Why?
|
| Nylons | 1 | 2012 | 12 | 0.020 |
Why?
|
| Tissue Adhesions | 1 | 2012 | 29 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2011 | 2862 | 0.020 |
Why?
|
| Gestational Age | 1 | 2016 | 1221 | 0.020 |
Why?
|
| Conjunctiva | 1 | 2013 | 197 | 0.020 |
Why?
|
| Sutures | 1 | 2012 | 63 | 0.020 |
Why?
|
| Coloring Agents | 1 | 2011 | 72 | 0.020 |
Why?
|
| Patient Compliance | 1 | 2013 | 469 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2013 | 1634 | 0.020 |
Why?
|
| Prognosis | 1 | 2019 | 4951 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 2355 | 0.020 |
Why?
|
| Foreign-Body Migration | 1 | 2008 | 58 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2016 | 3834 | 0.020 |
Why?
|
| Phenotype | 1 | 2016 | 4517 | 0.020 |
Why?
|
| Infant | 2 | 2015 | 13300 | 0.020 |
Why?
|
| Algorithms | 1 | 2013 | 1685 | 0.020 |
Why?
|
| Aging | 1 | 2012 | 1264 | 0.010 |
Why?
|
| Corneal Edema | 1 | 2003 | 11 | 0.010 |
Why?
|
| Ofloxacin | 1 | 2003 | 30 | 0.010 |
Why?
|
| Mutation | 1 | 2016 | 6177 | 0.010 |
Why?
|
| Animals | 1 | 2024 | 34341 | 0.010 |
Why?
|
| Glucocorticoids | 1 | 2003 | 350 | 0.010 |
Why?
|
| Anti-Infective Agents | 1 | 2003 | 265 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2011 | 4037 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2003 | 1168 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2010 | 8589 | 0.010 |
Why?
|